Dr. Pedro Rosa Neto

Neurologist

20160912-rosa-neto-head-shot

Dr. Pedro Rosa-Neto, MD (Federal University Rio Grande do Sul, Brazil) PhD (Aarhus University PET Centre, Denmark), is an associate professor of Neurology, Neurosurgery and Psychiatry at McGill University, affiliated to the Douglas Research Centre. He is a neurologist specialized in dementia with expertise in quantification of brain function using imaging techniques, in particular Positron Emission Tomography (PET). Dr. Rosa-Neto’s directs the laboratory for translational neuroimaging, which aims to innovate clinical trials in dementia by using imaging advances. In vivo quantification of Alzheimer’s disease pathophysiology, with emphasis on amyloid, neurofibrillary tangles, has been a significant emphasis of his research program leading to developments of several techniques to quantify target engagement, efficacy and disease progression in clinical populations. Dr. Rosa-Neto conducts research on new treatments to prevent and treat dementia symptoms at the McGill Alzheimer’s disease research Unit.

Dr. Rosa-Neto is an Fonds de Recherche Santé – Québec Scholar, the interim director of the McGill Centre for Studies in Aging and director of the Early Onset Dementia Clinic at the Douglas Hospital. He is the Chair and National Coordinator of PET of the CIHR-Canadian Consortium on Neurodegeneration in Aging (CCNA) and vice chair of the CCNA team 2 ‘Inflammation and Trophic Factor deregulation in Alzheimer’s disease. He is a committee member of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4).

Dr. Rosa-Neto research is funded by Alzheimer’s Association USA, Canadian Foundation for innervation (CFI), Fonds de Recherche Santé – Québec (FRQ-S), Canadian Institutes of Health Research (CIHR) and the Weston Brain Institute.

Dr. Pedro Rosa Neto Grants